Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) COO Michael Willem Waters sold 5,793 shares of the company’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total transaction of $73,513.17. Following the completion of the sale, the chief operating officer now directly owns 64,881 shares in the company, valued at $823,339.89. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Michael Willem Waters also recently made the following trade(s):
- On Friday, February 2nd, Michael Willem Waters sold 4,523 shares of Teladoc Health stock. The shares were sold at an average price of $19.18, for a total value of $86,751.14.
Teladoc Health Stock Performance
Shares of TDOC stock opened at $12.78 on Friday. Teladoc Health, Inc. has a fifty-two week low of $12.53 and a fifty-two week high of $30.41. The company has a debt-to-equity ratio of 0.67, a quick ratio of 3.47 and a current ratio of 3.82. The stock’s fifty day moving average is $14.44 and its two-hundred day moving average is $17.57.
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the business. ICA Group Wealth Management LLC purchased a new stake in shares of Teladoc Health in the fourth quarter valued at approximately $28,000. Hexagon Capital Partners LLC boosted its stake in Teladoc Health by 204.4% during the fourth quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock worth $34,000 after buying an additional 1,065 shares during the last quarter. RIA Advisory Group LLC purchased a new stake in Teladoc Health in the 4th quarter valued at $36,000. GAMMA Investing LLC acquired a new stake in shares of Teladoc Health in the 4th quarter worth $41,000. Finally, Principal Securities Inc. acquired a new stake in shares of Teladoc Health in the 4th quarter worth $45,000. 76.82% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several brokerages recently weighed in on TDOC. Royal Bank of Canada reduced their price target on Teladoc Health from $25.00 to $18.00 and set an “outperform” rating for the company in a research report on Friday, April 26th. Piper Sandler decreased their target price on shares of Teladoc Health from $30.00 to $25.00 and set an “overweight” rating for the company in a research note on Wednesday, February 21st. Barclays dropped their price target on shares of Teladoc Health from $25.00 to $20.00 and set an “overweight” rating on the stock in a research report on Friday, April 26th. Oppenheimer decreased their price objective on shares of Teladoc Health from $26.00 to $21.00 and set an “outperform” rating for the company in a research report on Friday, April 26th. Finally, Stifel Nicolaus dropped their target price on Teladoc Health from $21.00 to $16.00 and set a “hold” rating on the stock in a research report on Friday, April 26th. Twelve research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, Teladoc Health currently has an average rating of “Hold” and a consensus price target of $18.73.
Get Our Latest Research Report on Teladoc Health
About Teladoc Health
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Articles
- Five stocks we like better than Teladoc Health
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Appleās Earnings Show Investors Its Strength and Its Weakness
- Canada Bond Market Holiday: How to Invest and Trade
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- Do ETFs Pay Dividends? What You Need to Know
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.